Literature DB >> 6329966

Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells.

H Yoshikura, J Nishida, M Yoshida, Y Kitamura, F Takaku, S Ikeda.   

Abstract

HTLV was isolated in the human diploid fibroblast strain IMR90 directly from the leukemic cells of the Japanese ATL-patients. The infection was checked by the presence of virus-specific p24 and proviral DNA. The isolation was successful in three of four patients. The patient whose virus isolation was unsuccessful contained only a defective viral genome in his leukemic cells. The infected cells produced polykaryons when co-cultured with catS + L-cells. Human leukemia HL60 cells formed clusters adherent to the infected IMR90 cells but not to uninfected IMR90 cells. The former phenomenon was blocked by the ATLL patients' serum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329966     DOI: 10.1002/ijc.2910330606

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy.

Authors:  I Kitajima; K Yamamoto; K Sato; Y Nakajima; T Nakajima; I Maruyama; M Osame; K Nishioka
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.

Authors:  H Takashima; K Eguchi; A Kawakami; Y Kawabe; K Migita; M Sakai; T Origuchi; S Nagataki
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

3.  Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.

Authors:  Ayse Kubra Coskun; Richard E Sutton
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Frequent partial deletion of human adult T-cell leukemia virus type I proviruses in experimental transmission: pattern and possible implication.

Authors:  K Hiramatsu; H Yoshikura
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.

Authors:  Y Sagara; C Ishida; Y Inoue; H Shiraki; Y Maeda
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.

Authors:  J E Hildreth; A Subramanium; R A Hampton
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo.

Authors:  G Feuer; J K Fraser; J A Zack; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

Authors:  M Sakai; K Eguchi; K Terada; M Nakashima; I Yamashita; H Ida; Y Kawabe; T Aoyagi; H Takino; T Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.

Authors:  Josefina D Piñon; P J Klasse; Sushma R Jassal; Sandy Welson; Jonathan Weber; David W Brighty; Quentin J Sattentau
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis.

Authors:  B Ziegler; R E Gay; G Q Huang; H G Fassbender; S Gay
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.